Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Rubik’s Spark gives the classic children’s toy an injection of new technology

Add as a preferred source on Google

Invented in 1974, the Rubik’s Cube has been a staple childhood toy ever since the peak of its popularity in the 1980s. Now, the Rubik’s Spark is set to update the classic puzzle for a 21st century audience.

Like the original toy, the Rubik’s Spark is a cube that features nine individual squares on each of its six faces. The twist is that rather than rotating around a pivot, these squares light up individually, according to a report from Pocket Lint.

Recommended Videos

Players don’t actually rotate squares as they would on a traditional Rubik’s Cube. Instead, the Spark uses “bubble control” — sensors inside the device allow it to detect which way it’s oriented, so players can influence which square is illuminated at any given time by turning it over in their hands.

This novel gameplay mechanic is the foundation of several different game modes preinstalled on the Spark, none of which imitate the color-matching fun of the original Rubik’s Cube.

One mode sees players tasked with following a path that’s demonstrated for them. Another challenges them to light up certain squares by navigating around the face of the device, while being held to a stringent time limit.

The Rubik’s Spark features six game modes, and a bonus activity called Rubik’s DJ, where players can rotate the device to mix several looping instrumentals. There’s support for both single-player fun and multiplayer competition.

While it remains to be seen whether the Rubik’s Spark can become as ingrained in pop culture as the original Rubik’s Cube, it’s definitely a creative use of new technology to put a different spin on a kids’ classic. The Spark is set to retail for around $30, and is already available for purchase in some regions.

Brad Jones
Brad is an English-born writer currently splitting his time between Edinburgh and Pennsylvania. You can find him on Twitter…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more